Cancer Therapy: Protecting the Heart
Received Date: Nov 01, 2025 / Published Date: Dec 01, 2025
Abstract
Cardiac toxicity from cancer therapies is a growing concern. Several treatments, including \textit{Immune Checkpoint Inhibitors} (ICIs), anthracyclines, and trastuzumab, can cause significant cardiac issues. Early detection, monitoring, and multidisciplinary cardio-oncology programs are essential. Cardiac biomarkers and Artificial Intelligence (AI) hold promise for improving patient outcomes by predicting and managing these toxicities.
Citation: Verma N (2025) Cancer Therapy: Protecting the Heart . Toxicol Open Access 11: 340.
Copyright: © 2025 Nishant Verma This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
Article Usage
- Total views: 103
- [From(publication date): 0-0 - Dec 10, 2025]
- Breakdown by view type
- HTML page views: 72
- PDF downloads: 31
